254 related articles for article (PubMed ID: 26505124)
1. A combined CoMFA and CoMSIA 3D-QSAR study of benzamide type antibacterial inhibitors of the FtsZ protein in drug-resistant Staphylococcus aureus.
Andrades J; Campanini J; Vásquez D; Silvestri C; Morales C; Romero J; Mella J
SAR QSAR Environ Res; 2015; 26(11):925-42. PubMed ID: 26505124
[TBL] [Abstract][Full Text] [Related]
2. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZ.
Stokes NR; Baker N; Bennett JM; Chauhan PK; Collins I; Davies DT; Gavade M; Kumar D; Lancett P; Macdonald R; Macleod L; Mahajan A; Mitchell JP; Nayal N; Nayal YN; Pitt GR; Singh M; Yadav A; Srivastava A; Czaplewski LG; Haydon DJ
Bioorg Med Chem Lett; 2014 Jan; 24(1):353-9. PubMed ID: 24287381
[TBL] [Abstract][Full Text] [Related]
4. Structural insights of Staphylococcus aureus FtsZ inhibitors through molecular docking, 3D-QSAR and molecular dynamics simulations.
Ballu S; Itteboina R; Sivan SK; Manga V
J Recept Signal Transduct Res; 2018 Feb; 38(1):61-70. PubMed ID: 29369011
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators.
Bi F; Song D; Zhang N; Liu Z; Gu X; Hu C; Cai X; Venter H; Ma S
Eur J Med Chem; 2018 Nov; 159():90-103. PubMed ID: 30268826
[TBL] [Abstract][Full Text] [Related]
6. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.
Babu S; Sohn H; Madhavan T
Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus.
Song D; Bi F; Zhang N; Qin Y; Liu X; Teng Y; Ma S
Bioorg Med Chem; 2020 Nov; 28(21):115729. PubMed ID: 33065440
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and on-target antibacterial activity of novel 3-elongated arylalkoxybenzamide derivatives as inhibitors of the bacterial cell division protein FtsZ.
Ma S; Cong C; Meng X; Cao S; Yang H; Guo Y; Lu X; Ma S
Bioorg Med Chem Lett; 2013 Jul; 23(14):4076-9. PubMed ID: 23770057
[TBL] [Abstract][Full Text] [Related]
9. 2,6-Difluorobenzamide Inhibitors of Bacterial Cell Division Protein FtsZ: Design, Synthesis, and Structure-Activity Relationships.
Straniero V; Zanotto C; Straniero L; Casiraghi A; Duga S; Radaelli A; De Giuli Morghen C; Valoti E
ChemMedChem; 2017 Aug; 12(16):1303-1318. PubMed ID: 28586174
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ.
Czaplewski LG; Collins I; Boyd EA; Brown D; East SP; Gardiner M; Fletcher R; Haydon DJ; Henstock V; Ingram P; Jones C; Noula C; Kennison L; Rockley C; Rose V; Thomaides-Brears HB; Ure R; Whittaker M; Stokes NR
Bioorg Med Chem Lett; 2009 Jan; 19(2):524-7. PubMed ID: 19064318
[TBL] [Abstract][Full Text] [Related]
11. Effective GTP-replacing FtsZ inhibitors and antibacterial mechanism of action.
Artola M; Ruiz-Avila LB; Vergoñós A; Huecas S; Araujo-Bazán L; Martín-Fontecha M; Vázquez-Villa H; Turrado C; Ramírez-Aportela E; Hoegl A; Nodwell M; Barasoain I; Chacón P; Sieber SA; Andreu JM; López-Rodríguez ML
ACS Chem Biol; 2015 Mar; 10(3):834-43. PubMed ID: 25486266
[TBL] [Abstract][Full Text] [Related]
12. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
Qiu Y; Zhou L; Hu Y; Bao Y
J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological activity evaluation of novel 2,6-difluorobenzamide derivatives through FtsZ inhibition.
Bi F; Guo L; Wang Y; Venter H; Semple SJ; Liu F; Ma S
Bioorg Med Chem Lett; 2017 Feb; 27(4):958-962. PubMed ID: 28082038
[TBL] [Abstract][Full Text] [Related]
14. A benzamide-dependent ftsZ mutant reveals residues crucial for Z-ring assembly.
Adams DW; Wu LJ; Errington J
Mol Microbiol; 2016 Mar; 99(6):1028-42. PubMed ID: 26601800
[TBL] [Abstract][Full Text] [Related]
15. FtsZ inhibition: a promising approach for antistaphylococcal therapy.
Singh P; Panda D
Drug News Perspect; 2010 Jun; 23(5):295-304. PubMed ID: 20603653
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of tricyclic oxazolidinones as antibacterial agents.
Gopalakrishnan B; Khandelwal A; Rajjak SA; Selvakumar N; Das J; Trehan S; Iqbal J; Kumar MS
Bioorg Med Chem; 2003 Jun; 11(12):2569-74. PubMed ID: 12757724
[TBL] [Abstract][Full Text] [Related]
17. Benzodioxane-Benzamides as Antibacterial Agents: Computational and SAR Studies to Evaluate the Influence of the 7-Substitution in FtsZ Interaction.
Straniero V; Sebastián-Pérez V; Hrast M; Zanotto C; Casiraghi A; Suigo L; Zdovc I; Radaelli A; De Giuli Morghen C; Valoti E
ChemMedChem; 2020 Jan; 15(2):195-209. PubMed ID: 31750973
[TBL] [Abstract][Full Text] [Related]
18. 2/3D-QSAR, molecular docking and MD simulation studies of FtsZ protein targeting benzimidazoles derivatives.
Ahamad S; Islam A; Ahmad F; Dwivedi N; Hassan MI
Comput Biol Chem; 2019 Feb; 78():398-413. PubMed ID: 30602415
[TBL] [Abstract][Full Text] [Related]
19. Targeting the FtsZ Allosteric Binding Site with a Novel Fluorescence Polarization Screen, Cytological and Structural Approaches for Antibacterial Discovery.
Huecas S; Araújo-Bazán L; Ruiz FM; Ruiz-Ávila LB; Martínez RF; Escobar-Peña A; Artola M; Vázquez-Villa H; Martín-Fontecha M; Fernández-Tornero C; López-Rodríguez ML; Andreu JM
J Med Chem; 2021 May; 64(9):5730-5745. PubMed ID: 33908781
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors.
Bhatt HG; Patel PK
Bioorg Med Chem Lett; 2012 Jun; 22(11):3758-65. PubMed ID: 22546667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
